🇺🇸 FDA
Patent

US 8871206

Anti-human folate receptor beta antibodies and methods of use

granted A61KA61K38/00A61K47/6849

Quick answer

US patent 8871206 (Anti-human folate receptor beta antibodies and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61K47/6849, A61K47/6911, A61K47/6913